Costs and Outcomes of Acute Kidney Injury in Critically Ill Patients with Cancer

Journal of Supportive Oncology

Volumn 9, Issue 4, 2011, Pages 149-155

  Lahoti, Amit ^a   Nates, Joseph L ^a   Wakefield, Chris D ^a   Price, Kristen J ^a   Salahudeen, Abdulla K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CANCER PATIENT; CAUCASIAN; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DIALYSIS; DISEASE SEVERITY; DISEASE SURVEILLANCE; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HOSPITAL COST; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SEPSIS; BLOOD; CRITICAL ILLNESS; ECONOMICS; MIDDLE AGED; NEOPLASM; STATISTICAL MODEL;

CREATININE;

ACUTE KIDNEY INJURY; AGED; CREATININE; CRITICAL ILLNESS; FEMALE; HOSPITAL COSTS; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 80051636284     PISSN: 15446794     EISSN: 1879596X     Source Type: Journal    
DOI: 10.1016/j.suponc.2011.03.008     Document Type: Article

References (39)

1. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 2002, 360:1131-1135.
2. Darmon M., Ciroldi M., Thiery G., Schlemmer B., Azoulay E. Clinical review: specific aspects of acute renal failure in cancer patients. Crit Care 2006, 10:211.
3. Evison J., Rickenbacher P., Ritz R., Gratwohl A., Haberthür C., Elsasser S., Passweg J.R. Intensive care unit admission in patients with haematological disease: incidence, outcome and prognostic factors. Swiss Med Wkly 2001, 131:681-686.
4. Chertow G.M., Burdick E., Honour M., Bonventre J.V., Bates D.W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005, 16:3365-3370.
5. Dasta J.F., Kane-Gill S.L., Durtschi A.J., Pathak D.S., Kellum J.A. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 2008, 23:1970-1974.
6. Stevens L.A., Coresh J., Greene T., Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473-2483.
7. Launay-Vacher V., Izzedine H., Rey J.B., Rixe O., Chapalain S., Nourdine S., Paci A., Bourget P., Deray G. Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients. Med Sci Monit 2004, 10:CR209-CR212.
8. Dogan E., Izmirli M., Ceylan K., Erkoc R., Sayarlioglu H., Begenik H., Alici S. Incidence of renal insufficiency in cancer patients. Adv Ther 2005, 22:357-362.
9. Kellum J.A., Levin N., Bouman C., Lameire N. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 2002, 8:509-514.
10. Hoste E.A., Schurgers M. Epidemiology of acute kidney injury: how big is the problem?. Crit Care Med 2008, 36:S146-S151.
11. Lahoti A., Kantarjian H., Salahudeen A.K., Ravandi F., Cortes J.E., Faderl S., O'Brien S., Wierda W., Mattiuzzi G.N. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Cancer 2010, 116:4063-4068.
12. Hoste E.A., Clermont G., Kersten A., Venkataraman R., Angus D.C., De Bacquer D., Kellum J.A. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006, 10:R73.
13. Kuitunen A., Vento A., Suojaranta-Ylinen R., Pettilä V. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg 2006, 81:542-546.
14. Lopes J.A., Jorge S., Silva S., de Almeida E., Abreu F., Martins C., do Carmo J.A., Lacerda J.F., Prata M.M. An assessment of the RIFLE criteria for acute renal failure following myeloablative autologous and allogeneic haematopoietic cell transplantation. Bone Marrow Transplant 2006, 38:395.
15. Jenq C.C., Tsai M.H., Tian Y.C., Lin C.Y., Yang C., Liu N.J., Lien J.M., Chen Y.C., Fang J.T., Chen P.C., Yang C.W. RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients. Intensive Care Med 2007, 33:1921-1930.
16. Lopes J.A., Jorge S., Neves F.C., Caneira M., da Costa A.G., Ferreira A.C., Prata M.M. An assessment of the RIFLE criteria for acute renal failure in severely burned patients. Nephrol Dial Transplant 2007, 22:285.
17. O'Riordan A., Wong V., McQuillan R., McCormick P.A., Hegarty J.E., Watson A.J. Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation. Am J Transplant 2007, 7:168-176.
18. Lopes J.A., Fernandes J., Jorge S., Neves J., Antunes F., Prata M.M. An assessment of the RIFLE criteria for acute renal failure in critically ill HIV-infected patients. Crit Care 2007, 11:401.
19. Mehta R.L., Kellum J.A., Shah S.V., Molitoris B.A., Ronco C., Warnock D.G., Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31.
20. Salahudeen A.K., Kumar V., Madan N., Xiao L., Lahoti A., Samuels J., Nates J., Price K. Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. Clin J Am Soc Nephrol 2009, 4:1338-1346.
21. Skrepnek G.H. Regression methods in the empiric analysis of health care data. J Manag Care Pharm 2005, 11:240-251.
22. Trotti A., Colevas A.D., Setser A., Rusch V., Jaques D., Budach V., Langer C., Murphy B., Cumberlin R., Coleman C.N., Rubin P. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003, 13:176-181.
23. Parikh C.R., Jani A., Melnikov V.Y., Faubel S., Edelstein C.L. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004, 43:405-414.
24. Mishra J., Mori K., Ma Q., Kelly C., Barasch J., Devarajan P. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004, 24:307-315.
25. Ichimura T., Hung C.C., Yang S.A., Stevens J.L., Bonventre J.V. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 2004, 286:F552-F563.
26. Yao Q., Axelsson J., Heimburger O., Stenvinkel P., Lindholm B. Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences. Minerva Urol Nefrol 2004, 56:237-248.
27. Paladino J.D., Hotchkiss J.R., Rabb H. Acute kidney injury and lung dysfunction: a paradigm for remote organ effects of kidney disease?. Microvasc Res 2009, 77:8-12.
28. Rabb H., Wang Z., Nemoto T., Hotchkiss J., Yokota N., Soleimani M. Acute renal failure leads to dysregulation of lung salt and water channels. Kidney Int 2003, 63:600-606.
29. Zager R.A. Acute renal failure in the setting of bone marrow transplantation. Kidney Int 1994, 46:1443-1458.
30. Joannidis M., Metnitz P.G. Epidemiology and natural history of acute renal failure in the ICU. Crit Care Clin 2005, 21:239-249.
31. Lameire N., Van Biesen W., Vanholder R. The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol 2006, 2:364-377.
32. Kroschinsky F., Weise M., Illmer T., Haenel M., Bornhaeuser M., Hoeffken G., Ehninger G., Schuler U. Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med 2002, 28:1294-1300.
33. Benoit D.D., Vandewoude K.H., Decruyenaere J.M., Hoste E.A., Colardyn F.A. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 2003, 31:104-112.
34. Lamia B., Hellot M.F., Girault C., Tamion F., Dachraoui F., Lenain P., Bonmarchand G. Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU. Intensive Care Med 2006, 32:1560-1568.
35. Silfvast T., Pettilä V., Ihalainen A., Elonen E. Multiple organ failure and outcome of critically ill patients with haematological malignancy. Acta Anaesthesiol Scand 2003, 47:301-306.
36. Merz T.M., Schär P., Bühlmann M., Takala J., Rothen H.U. Resource use and outcome in critically ill patients with hematological malignancy: a retrospective cohort study. Crit Care 2008, 12:R75.
37. Soares M., Salluh J.I., Carvalho M.S., Darmon M., Rocco J.R., Spector N. Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol 2006, 24:4003-4010.
38. Benoit D.D., Hoste E.A., Depuydt P.O., Offner F.C., Lameire N.H., Vandewoude K.H., Dhondt A.W., Noens L.A., Decruyenaere J.M. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrol Dial Transplant 2005, 20:552-558.
39. Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., Peterson E., Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377. Early Goal-Directed Therapy Collaborative Group.